Matches in SemOpenAlex for { <https://semopenalex.org/work/W3199597858> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W3199597858 endingPage "1346" @default.
- W3199597858 startingPage "1345" @default.
- W3199597858 abstract "LettersSeptember 2021Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune DiseaseMonique K. van der Kooij, MD, Karijn P.M. Suijkerbuijk, MD, PhD, Olaf M. Dekkers, MD, PhD, Ellen Kapiteijn, MD, PhDMonique K. van der Kooij, MDSearch for more papers by this author, Karijn P.M. Suijkerbuijk, MD, PhDSearch for more papers by this author, Olaf M. Dekkers, MD, PhDSearch for more papers by this author, Ellen Kapiteijn, MD, PhDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L21-0442 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE: We thank Dr. Yang and colleagues for their interest in our article and would like to respond to the concerns that they raised.First, Dr. Yang and colleagues contend that the prevalence and severity of immune-related adverse events would have differed if we had excluded patients with preexisting thyroid disorders. They refer to a phase 1b trial in which—as in most currently recruiting checkpoint inhibitor trials—thyroid disorders are not an exclusion criterion. Because our aim was to include all autoimmune disorders, we explicitly included both hypo- and hyperthyroidism. However, in Appendix Tables 5 to 7 of our article, ... Author, Article, and Disclosure InformationAffiliations: Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M20-3419. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoSafety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease Monique K. van der Kooij , Karijn P.M. Suijkerbuijk , Maureen J.B. Aarts , Franchette W.P.J. van den Berkmortel , Christian U. Blank , Marye J. Boers-Sonderen , Jesper van Breeschoten , Alfonsus J.M. van den Eertwegh , Jan Willem B. de Groot , John B.A.G. Haanen , Geke A.P. Hospers , Djura Piersma , Rozemarijn S. van Rijn , Albert J. ten Tije , Astrid A.M. van der Veldt , Gerard Vreugdenhil , Michiel C.T. van Zeijl , Michel W.J.M Wouters , Olaf M. Dekkers , and Ellen Kapiteijn Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease Xi Yang , Lilit Karapetyan , and John M. Kirkwood Metrics September 2021Volume 174, Issue 9Page: 1345-1346 ePublished: 21 September 2021 Issue Published: September 2021 Copyright & PermissionsCopyright © 2021 by American College of Physicians. All Rights Reserved.PDF downloadLoading ..." @default.
- W3199597858 created "2021-09-27" @default.
- W3199597858 creator A5031300611 @default.
- W3199597858 creator A5061860913 @default.
- W3199597858 creator A5069014026 @default.
- W3199597858 creator A5087767413 @default.
- W3199597858 date "2021-09-01" @default.
- W3199597858 modified "2023-10-17" @default.
- W3199597858 title "Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease" @default.
- W3199597858 doi "https://doi.org/10.7326/l21-0442" @default.
- W3199597858 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34543594" @default.
- W3199597858 hasPublicationYear "2021" @default.
- W3199597858 type Work @default.
- W3199597858 sameAs 3199597858 @default.
- W3199597858 citedByCount "3" @default.
- W3199597858 countsByYear W31995978582022 @default.
- W3199597858 countsByYear W31995978582023 @default.
- W3199597858 crossrefType "journal-article" @default.
- W3199597858 hasAuthorship W3199597858A5031300611 @default.
- W3199597858 hasAuthorship W3199597858A5061860913 @default.
- W3199597858 hasAuthorship W3199597858A5069014026 @default.
- W3199597858 hasAuthorship W3199597858A5087767413 @default.
- W3199597858 hasConcept C121608353 @default.
- W3199597858 hasConcept C126322002 @default.
- W3199597858 hasConcept C143998085 @default.
- W3199597858 hasConcept C197934379 @default.
- W3199597858 hasConcept C2777658100 @default.
- W3199597858 hasConcept C2777701055 @default.
- W3199597858 hasConcept C2779134260 @default.
- W3199597858 hasConcept C2780851360 @default.
- W3199597858 hasConcept C502942594 @default.
- W3199597858 hasConcept C71924100 @default.
- W3199597858 hasConceptScore W3199597858C121608353 @default.
- W3199597858 hasConceptScore W3199597858C126322002 @default.
- W3199597858 hasConceptScore W3199597858C143998085 @default.
- W3199597858 hasConceptScore W3199597858C197934379 @default.
- W3199597858 hasConceptScore W3199597858C2777658100 @default.
- W3199597858 hasConceptScore W3199597858C2777701055 @default.
- W3199597858 hasConceptScore W3199597858C2779134260 @default.
- W3199597858 hasConceptScore W3199597858C2780851360 @default.
- W3199597858 hasConceptScore W3199597858C502942594 @default.
- W3199597858 hasConceptScore W3199597858C71924100 @default.
- W3199597858 hasIssue "9" @default.
- W3199597858 hasLocation W31995978581 @default.
- W3199597858 hasOpenAccess W3199597858 @default.
- W3199597858 hasPrimaryLocation W31995978581 @default.
- W3199597858 hasRelatedWork W2021968456 @default.
- W3199597858 hasRelatedWork W2068861579 @default.
- W3199597858 hasRelatedWork W2215031211 @default.
- W3199597858 hasRelatedWork W2412245334 @default.
- W3199597858 hasRelatedWork W2429247496 @default.
- W3199597858 hasRelatedWork W2619461121 @default.
- W3199597858 hasRelatedWork W2937983190 @default.
- W3199597858 hasRelatedWork W2981372661 @default.
- W3199597858 hasRelatedWork W2981745426 @default.
- W3199597858 hasRelatedWork W4316467054 @default.
- W3199597858 hasVolume "174" @default.
- W3199597858 isParatext "false" @default.
- W3199597858 isRetracted "false" @default.
- W3199597858 magId "3199597858" @default.
- W3199597858 workType "article" @default.